首页 > 市场调查报告书 > 製药

以基因为基之药物开发

市场调查报告书

商品编码

1547294

全球基因组个人化健康市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Genomics Personalized Health Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球基因组个人化健康市场需求预计将从 2023 年的 567.8 亿美元增至 2032 年的近 874.1 亿美元，2024-2032 年研究期间复合年增长率为 4.91%。

基因组个人化健康是一种独特的医疗保健方法，其中根据遗传资讯修改患者的医疗治疗。随着对人类基因组的更好理解以及医生在患者的医疗和外科管理中使用这些资讯的方式的发展，一个更复杂的系统已经发展起来。这些可以帮助诊断各种复杂的疾病，并导致基于基因分析的更客製化的治疗方法的开发，消除一些可能在特定患者群体中失败或产生不良副作用的传统药物。该研究重点是基因组发现、分析和翻译方法的设计、开发和使用，以促进基因组学驱动的医疗保健并改善临床和个人化健康结果。个人化医疗是一个新领域，它利用个人的基因谱来帮助指导有关疾病预防、诊断和治疗的决策。医生可以利用患者的基因谱来帮助他们选择合适的药物或疗法，并以正确的剂量或方案进行给药。

市场动态

全球基因组学个人化健康市场是由生物标记相关研发活动支出不断增加所推动的。随着癌症和糖尿病等慢性疾病变得更加普遍，对基于基因组学的个人化健康的需求预计将会增加。製药业的扩张以及治疗反应的评估和预测预计将推动该行业向前发展。此外，个人化基因组学健康市场受到蓬勃发展的分子生物学领域和医疗保健领域技术进步的影响。同样，老年人口的成长增加了多种慢性病的盛行率，促进了市场的成长。诊断医疗保健和政府增加的投资预计将成为基因组学个人化健康市场成长的关键驱动力。然而，新兴国家缺乏意识、耗时的监管规则、资料安全和监管问题以及重大资料管理问题阻碍了市场扩张。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球基因组个人化健康市场的每个细分市场进行了包容性评估。基因组学个人化健康产业的成长和趋势为这项研究提供了整体方法。

市场区隔

基因组学个人化健康市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

依技术

NGS平台
逆转录聚合酶连锁反应
微阵列
基因分析仪

通过测试

肿瘤学测试
传染病检测
自体免疫疾病检测
其他的

按最终用户

学术界及研究机构
诊断中心
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲基因组个人化健康市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。基因组个人化健康市场的主要参与者包括 Illumine、QIAGEN、Thermo Fisher Scientific、Bio-Rad Laboratories、Roche、Lonza Group。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：基因组个人化健康公司的竞争格局

基因组学个人化健康市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Illumine

公司概况
公司收入
产品
最新动态

QIAGEN

公司概况
公司收入
产品
最新动态

Thermo Fisher Scientific

公司概况
公司收入
产品
最新动态

Bio-Rad Laboratories

公司概况
公司收入
产品
最新动态

Roche

公司概况
公司收入
产品
最新动态

Lonza Group

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11216670

The global demand for Genomics Personalized Health Market is presumed to reach the market size of nearly USD 87.41 Billion by 2032 from USD 56.78 Billion in 2023 with a CAGR of 4.91% under the study period 2024-2032.

Genomic personalized health is a unique approach to healthcare in which a patient's medical treatment is modified based on genetic information. A more sophisticated system has evolved from a better understanding of the human genome and ways for physicians to use that information in their patients' medical and surgical management. These can aid in diagnosing a wide range of complex disorders and lead to the development of more customized treatments based on genetic profiling, removing some conventional medications that may fail or have adverse side effects in a specific patient population. The research focuses on the design, development, and use of genomic discovery, analysis, and translation methodologies to promote genomics-driven healthcare and improve clinical and personalized health outcomes. Personalized medicine is a new field that uses a person's genetic profile to help guide decisions about illness prevention, diagnosis, and treatment. Doctors can use a patient's genetic profile to assist them in choosing the proper medication or therapy for them and administer it at the correct dose or regimen.

MARKET DYNAMICS

The global genomics personalized health market is driven by rising spending on research and development activities tied to biomarkers. Demand for genomics-based personalized health is expected to increase as chronic diseases like cancer and diabetes become more prevalent. The pharmaceutical sector's expansion and the assessment and prediction of treatment response are projected to propel the industry forward. Furthermore, the personalized genomics health market is affected by the booming molecular biology sector and technological advancements in the healthcare sector. Again, the growing elderly population has increased the prevalence of several chronic diseases, boosting the market's growth. Increased investment by diagnostic health care and governments is expected to be a critical driver of the genomics personalized health market's growth. However, the market expansion is hampered by a lack of awareness in emerging nations, time-consuming regulatory rules, data security and regulatory concerns, and significant data management issues.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Genomics Personalized Health. The growth and trends of Genomics Personalized Health industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Genomics Personalized Health market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

NGS Platforms
RT-PCR
Microarray
Genetic Analyzers

By Test

Oncology Testing
Infectious Disease Testing
Autoimmune Disease Testing
Others

By End-User

Academics & Research Institutes
Diagnostic Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Genomics Personalized Health market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Genomics Personalized Health market include Illumine, QIAGEN, Thermo Fisher Scientific, Bio-Rad Laboratories, Roche, Lonza Group. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. GENOMICS PERSONALIZED HEALTH - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Test
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET ANALYSIS BY TECHNOLOGY

5.1. Overview By Technology
5.2. Historical and Forecast Data Analysis By Technology
5.3. NGS Platforms Historic and Forecast Sales By Regions
5.4. RT-PCR Historic and Forecast Sales By Regions
5.5. Microarray Historic and Forecast Sales By Regions
5.6. Genetic Analyzers Historic and Forecast Sales By Regions

6. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET ANALYSIS BY TEST

6.1. Overview By Test
6.2. Historical and Forecast Data Analysis By Test
6.3. Oncology Testing Historic and Forecast Sales By Regions
6.4. Infectious Disease Testing Historic and Forecast Sales By Regions
6.5. Autoimmune Disease Testing Historic and Forecast Sales By Regions
6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET ANALYSIS BY END-USER

7.1. Overview By End-User
7.2. Historical and Forecast Data Analysis By End-User
7.3. Academics & Research Institutes Historic and Forecast Sales By Regions
7.4. Diagnostic Centers Historic and Forecast Sales By Regions
7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE GENOMICS PERSONALIZED HEALTH COMPANIES

9.1. Genomics Personalized Health Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF GENOMICS PERSONALIZED HEALTH INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Illumine
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. QIAGEN
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Thermo Fisher Scientific
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Bio-Rad Laboratories
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Roche
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Lonza Group
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments